- Home
- News
- Articles+
- Aerospace
- Agriculture
- Alternate Dispute Resolution
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- FDI
- Food and Beverage
- Health Care
- IBC Diaries
- Insurance Law
- Intellectual Property
- International Law
- Know the Law
- Labour Laws
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Technology Media and Telecom
- Tributes
- Zoom In
- Take On Board
- In Focus
- Law & Policy and Regulation
- IP & Tech Era
- Viewpoint
- Arbitration & Mediation
- Tax
- Student Corner
- AI
- ESG
- Gaming
- Inclusion & Diversity
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
- News
- Articles
- Aerospace
- Agriculture
- Alternate Dispute Resolution
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- FDI
- Food and Beverage
- Health Care
- IBC Diaries
- Insurance Law
- Intellectual Property
- International Law
- Know the Law
- Labour Laws
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Technology Media and Telecom
- Tributes
- Zoom In
- Take On Board
- In Focus
- Law & Policy and Regulation
- IP & Tech Era
- Viewpoint
- Arbitration & Mediation
- Tax
- Student Corner
- AI
- ESG
- Gaming
- Inclusion & Diversity
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
Khaitan & Co. Advised Advent International On $1.6 Billion Sale Of Bharat Serums And Vaccines To Mankind Pharma
Khaitan & Co. Advised Advent International On $1.6 Billion Sale Of Bharat Serums And Vaccines To Mankind Pharma
Khaitan & Co. advised Advent International on sale of its entire shareholding in Bharat Serums and Vaccines Limited to Mankind Pharma Limited, in a bid process. The Firm advised on all aspect of the transaction, including vendor diligence, assistance with the bid process, negotiating and finalising transaction documents, and advising on competition law and other regulatory aspects. The deal value is USD 1.6 billion.
The core team consisted of Partners Aakash Choubey, Aashutosh Sampat, Anshuman Mozumdar, Sameer Sah, with Senior Associates Ayush Sinha, Sagarika Chandel, and Associates Abhishek Singh, Aditi Halder, Amogh Pareek, Ankush Unni, and Arun Kumar Balasundar. with assistance from the following:
Vendor Diligence:
• Partners: Abhiraj Gandhi, Adheesh Nargolkar, Anshul Prakash, Kartikey Mahajan, Riya Bhattacharjee, Supratim Chakraborty, Swathy Ramanath
• Counsels: Abhimanyu Pal, Rishabh Vora, Sumantra Bose
• Principal Associates: Himanshu Tripathi, Kruthi Murthy
• Senior Associates: Anjuli Hora, Bhavya Chengappa, Ketan Jikar, Shramana Dwibedi, Sunaina Brahma
• Associates: Aayushi Singh, Ajeta Anand, Jishan Gaffar Dediwal, Paarth Samdani, Rishabh Kumar
Financing Aspects:
• Partner: Manisha Shroff
• Counsel: Arijit Sarkar
• Senior Associates: Rajshekhar Upadhyaya, Siddarth Goel
• Associate: Mayank Chaturvedi
Competition Aspects:
• Partner: Anshuman Sakle
• Principal Associate: Tanveer Verma
• Associate: Shravya Devaraj
• Insurance Aspects Team:
• Partner: Harsh Khemka
Structure Related Aspects:
• Partners: Sanjeev Kapoor, Shabnam Shaikh
• Director: Rahul Jain
• Counsels: Gaurav Malhotra, Hirak Mukhopadhyay
• Associates: Anushka Venketram, Gaurang Mansinghka